FDA Inspection 696655 — The Procter & Gamble Company

The Procter & Gamble Company — FEI 3003601023

The FDA completed an inspection of The Procter & Gamble Company on November 4, 2010 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 4, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Unapproved and Misbranded Drugs
Location
Cincinnati, OH (United States)